{"nct_id":"NCT06947928","title":"Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma","status":"NOT_YET_RECRUITING","status_verified_date":"2025-06","start_date":"2025-06-30","start_date_type":"ESTIMATED","primary_completion_date":"2027-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2032-12-30","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["HURA"]}